How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
35
CMZOF Quote, Financials, Valuation and Earnings
Last price:
$3.04
Seasonality move
:
0%
Day range:
$3.04 - $3.04
52-week range:
$3.04 - $3.04
Dividend yield:
9.17%
P/E ratio:
6.85x
P/S ratio:
2.29x
P/B ratio:
3.24x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$2.6B
Revenue:
$1.1B
EPS (TTM):
$0.44
Analysts' Opinion
-
Consensus RatingCorporacion Moctezuma SAB de CV has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Corporacion Moctezuma SAB de CV has an estimated downside of -- from its current price of $3.04.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $3.04.
Fair Value
-
According to the consensus of 0 analysts, Corporacion Moctezuma SAB de CV has -- downside to fair value with a price target of -- per share.
CMZOF vs. S&P 500
-
Over the past 5 trading days, Corporacion Moctezuma SAB de CV has underperformed the S&P 500 by -1.77% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Corporacion Moctezuma SAB de CV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Corporacion Moctezuma SAB de CV revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Corporacion Moctezuma SAB de CV reported revenues of $261.5M.
Earnings Growth
-
Corporacion Moctezuma SAB de CV earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Corporacion Moctezuma SAB de CV reported earnings per share of $0.10.
Enterprise value:
2.2B
EV / Invested capital:
2.73x
Price / LTM sales:
2.29x
EV / EBIT:
4.10x
EV / Revenue:
1.92x
PEG ratio (5yr expected):
0.31x
EV / Free cash flow:
8.57x
Price / Operating cash flow:
10.21x
Enterprise value / EBITDA:
3.83x
Gross Profit (TTM):
$743.1M
Return On Assets:
38.55%
Net Income Margin (TTM):
33.38%
Return On Equity:
47.1%
Return On Invested Capital:
47.1%
Operating Margin:
40.54%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $771.9M | $1.1B | $1.1B | $289.9M | $261.5M | |
| Gross Profit | $438.1M | $659M | $743.1M | $188.2M | $167.6M | |
| Operating Income | $279M | $423.8M | $482.1M | $119.1M | $106M | |
| EBITDA | $318.5M | $470.8M | $570.1M | $140.4M | $131.2M | |
| Diluted EPS | $0.24 | $0.36 | $0.44 | $0.11 | $0.10 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $253.2M | $331.1M | $373.1M | $518.1M | $538.6M | |
| Total Assets | $570.7M | $663M | $713.8M | $933.8M | $959.3M | |
| Current Liabilities | $71M | $81.9M | $109.9M | $148.1M | $142.7M | |
| Total Liabilities | $102M | $104.8M | $120.1M | $161.2M | $158.9M | |
| Total Equity | $468.7M | $558.2M | $593.6M | $772.6M | $800.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $235.9M | $365.1M | $331.9M | $88.4M | $64.7M | |
| Cash From Investing | -$16.4M | -$26.3M | -$39.8M | -$8.9M | -$23.3M | |
| Cash From Financing | -$190M | -$228.6M | -$246.4M | -$7.8M | $12M | |
| Free Cash Flow | $210M | $309.7M | $254.7M | $70.4M | $34.4M | |
CMZOF
Sector
Market Cap
$2.6B
$18.9M
Price % of 52-Week High
100%
57.66%
Dividend Yield
9.17%
0%
Shareholder Yield
10.11%
1.61%
1-Year Price Total Return
--
-18.53%
Beta (5-Year)
--
1.064
Dividend yield:
9.17%
Annualized payout:
$0.23
Payout ratio:
60.29%
Growth streak:
3 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$3.04
200-day SMA
Sell
Level
$3.04
Bollinger Bands (100)
Sell
Level
3.04 - 3.04
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$3.04
Relative Strength Index (RSI14)
Sell
Level
0.00
ADX Line
Neutral
Level
Williams %R
Buy
Level
0
50-day SMA
Sell
Level
$3.04
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
600
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (11.2588)
Buy
CA Score
(Annual)
Level (3.895)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-7.0458)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Corporacion Moctezuma SAB de CV is a Mexico-based company which is engaged in the production and sale of cement and ready-mix concrete. The product portfolio of the includes of compound Portland cements, white cement and mortar and others.
Stock Forecast FAQ
In the current month, CMZOF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CMZOF average analyst price target in the past 3 months is --.
-
Where Will Corporacion Moctezuma SAB de CV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Corporacion Moctezuma SAB de CV share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Corporacion Moctezuma SAB de CV?
Analysts are divided on their view about Corporacion Moctezuma SAB de CV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Corporacion Moctezuma SAB de CV is a Sell and believe this share price will rise from its current level to --.
-
What Is Corporacion Moctezuma SAB de CV's Price Target?
The price target for Corporacion Moctezuma SAB de CV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CMZOF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Corporacion Moctezuma SAB de CV is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CMZOF?
You can purchase shares of Corporacion Moctezuma SAB de CV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Corporacion Moctezuma SAB de CV shares.
-
What Is The Corporacion Moctezuma SAB de CV Share Price Today?
Corporacion Moctezuma SAB de CV was last trading at $3.04 per share. This represents the most recent stock quote for Corporacion Moctezuma SAB de CV. Yesterday, Corporacion Moctezuma SAB de CV closed at $3.04 per share.
-
How To Buy Corporacion Moctezuma SAB de CV Stock Online?
In order to purchase Corporacion Moctezuma SAB de CV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
